OC
VCEL icon

Oppenheimer & Co’s Vericel Corp VCEL Stock Holding History

Oppenheimer & Co’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,600
Closed -$34K – 1472
2013
Q4 		$34K Buy
10,600
+7,600
+253% +$29.7K ﹤0.01% 1359
2013
Q3 		$17K Buy
+3,000
New +$21.4K ﹤0.01% 1305

Other funds holding VCEL

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Oppenheimer & Co's VCEL Position: Q1 2014 in Review

Oppenheimer & Co sold out of Vericel Corp (VCEL) in Q1 2014, closing a stake of 10,600 shares — an estimated $34K sold.

Oppenheimer & Co first reported a position in VCEL in Q3 2013 and held it in 2 quarters. The position peaked at $34K in Q4 2013. 20 funds tracked by Wall St. Rank hold VCEL as of Q1 2014.

  • Oppenheimer & Co reported no remaining Vericel Corp position as of Q1 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 10,600 Vericel Corp shares in Q1 2014, an estimated $34K.
  • Oppenheimer & Co first reported a position in Vericel Corp in Q3 2013 and held it in 2 quarters.
  • Oppenheimer & Co's Vericel Corp position peaked at $34K in Q4 2013.
  • 20 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2014.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.